Literature DB >> 7648061

Antegrade scrotal sclerotherapy for the treatment of varicocele in childhood and adolescence.

A M Mottrie1, Y Matani, J Baert, G E Voges, R Hohenfellner.   

Abstract

OBJECTIVE: To test the efficacy of antegrade scrotal sclerotherapy (ASS) for the treatment of varicocele in teenagers. PATIENTS AND METHODS: The study included 38 patients (mean age 14.9 years, range 12-18) with left-sided varicocele. Three patients had a grade 1 varicocele, 22 were grade 2 and 13 were grade 3. ASS was performed under local anaesthesia on an out-patient basis.
RESULTS: ASS was accepted by all patients except one. There were no peri-operative problems and only one patient developed post-operative epididymitis. During 9 to 15 months of follow-up (mean 11 months), only two patients developed persistence of a lower grade of varicocele.
CONCLUSION: This study illustrates that ASS is a safe and successful out-patient procedure for the treatment of varicocele in teenagers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648061     DOI: 10.1111/j.1464-410x.1995.tb07825.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

Review 1.  [Antegrade sclerotherapy for varicocele testis--possible and avoidable complications].

Authors:  R Tauber; D Pfeiffer
Journal:  Urologe A       Date:  2003-09       Impact factor: 0.639

2.  Current management of adolescent varicocele.

Authors:  D A Paduch; S J Skoog
Journal:  Rev Urol       Date:  2001

3.  Antegrade pampiniform plexus venography in recurrent varicocele: Case report and anatomy review.

Authors:  Vyacheslav Gendel; Ihab Haddadin; John L Nosher
Journal:  World J Radiol       Date:  2011-07-28

4.  Percutaneous retrograde varicocele embolisation using tungsten embolisation coils: a five year audit.

Authors:  S R Keoghane; L Jones; M P Wright; J Kabala
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

5.  Management options of varicoceles.

Authors:  Peter Chan
Journal:  Indian J Urol       Date:  2011-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.